3,4-Difluorobenzonitrile

We are 3,4-Difluorobenzonitrile CAS:64248-62-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3,4-Difluorobenzonitrile
CAS.NO:64248-62-0
Synonyms:3,4-Difluorobenzonitrile
Benzonitrile,3,4-difluoro
4-CYANO-1,2-DIFLUOROBENZENE
Molecular Formula:C7H3F2N
Molecular Weight:139.10200
 
Physical and Chemical Properties:
Density:1.26
Melting point:52-54ºC
Boiling point:180ºC
Flash point:157°F
Index of Refraction:1.486
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical、pesticide and liquid crystal material intermediate

3,4-Difluorobenzonitrile


Related News: Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.41556-26-7 Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.L-CYSTEINE The fine and functional chemicals sector provides new growth drivers.VINYLTRIS(TERT-BUTYLPEROXY)SILANE CAS:15188-09-7 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.

Related Products
Product Name
2,3-Difluoro-5-methylbenzoic acid View Details
(2S)-2-amino-3-(1-tritylimidazol-4-yl)propanoic acid View Details
2,4,5-Trifluorobenzoic acid View Details
diethyl phosphonate manufacturer Serinol manufacturer 2,5-Bis(trifluoromethyl)bromobenzene manufacturer 3-Aminophenol hemisulfate manufacturer 2-Bromovaleric acid manufacturer